Phreesia Shares Surge 5.1% Driven by Investor Optimism
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2026
0mins
Should l Buy PHR?
Source: NASDAQ.COM
- Significant Price Increase: Phreesia's stock surged 5.1% in the last trading session to close at $11.77, with trading volume significantly exceeding normal levels, indicating heightened market confidence in its future performance.
- Investor Confidence Boost: Pale Fire Capital SE purchased 1,602,505 shares of Phreesia between March 17 and 19 for approximately $18.3 million, increasing its total holdings to 7,648,829 shares, which further bolstered market optimism about the company.
- Strong Earnings Expectations: Phreesia is expected to report quarterly earnings of $0.09 per share, reflecting a year-over-year increase of 181.8%, with revenues projected at $126.37 million, up 15.2% from the previous year, showcasing the company's growth potential.
- Market Focus: Although the consensus EPS estimate has remained unchanged over the past 30 days, research indicates a strong correlation between earnings estimate revisions and stock price movements, prompting investors to closely monitor Phreesia's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 8.380
Low
24.00
Averages
29.09
High
35.00
Current: 8.380
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Financial Comparison: PHREESIA reported a Q4 adjusted EBITDA of USD 29.4 million, indicating strong financial performance.
Industry Benchmark: In contrast, the estimate for IBESE's adjusted EBITDA stands at USD 28.1 million, highlighting a competitive landscape.
See More
- Fiscal Results Announcement: PHR EESIA has announced its fiscal results for the fourth quarter of 2026.
- Performance Overview: The results provide insights into the financial performance and economic standing of the organization during this period.
See More
- Market Rally: The S&P 500 index rose by 2.91%, the Dow Jones Industrial Average by 2.49%, and the Nasdaq 100 by 3.43%, reflecting market optimism regarding the potential end of the Iran war, which could lower energy prices and ease inflation concerns.
- Consumer Confidence Boost: The US March consumer confidence index unexpectedly increased by 0.8 to 91.8, surpassing the anticipated decline to 87.9, indicating a strengthening consumer outlook that may drive spending and economic growth.
- Strength in China: China's March manufacturing PMI rose to 50.4, better than the expected 50.1, signaling signs of economic recovery that could positively impact global growth prospects and further support US stock performance.
- Falling Bond Yields: The 10-year Treasury note yield dropped to 4.28%, a one-week low, reflecting reduced inflation worries, which may provide support for the stock market and enhance investor interest in equities.
See More
- Oversold Signal: Phreesia Inc (Ticker: PHR) saw its RSI drop to 26.0 during Tuesday's trading, indicating that its stock price, which hit a low of $7.77, has entered oversold territory, suggesting that recent heavy selling may be nearing exhaustion and providing potential buying opportunities for investors.
- Market Comparison: Compared to the current RSI of 43.5 for the S&P 500 ETF (SPY), PHR's oversold condition may attract bullish investors, particularly in a market where overall performance remains relatively strong, potentially leading to increased capital inflow.
- Price Volatility: With a 52-week low of $7.77 and a high of $32.76, PHR's current trading price of $8.38 indicates significant price fluctuations, suggesting potential for a rebound that may catch the attention of short-term traders.
- Investor Sentiment: Despite the current low stock price, investor sentiment towards PHR may turn optimistic due to the oversold signal, especially as interest in other oversold stocks rises, which could drive its stock price higher.
See More
- Market Sentiment Improves: The S&P 500 index rose by 1.02%, the Dow Jones Industrial Average increased by 0.67%, and the Nasdaq 100 surged by 1.10% as President Trump signaled a willingness to end military actions against Iran, reflecting investor optimism over easing geopolitical risks.
- Falling Bond Yields: The 10-year Treasury note yield dropped to a one-week low of 4.30%, indicating market expectations that an end to the Iran conflict could lower energy prices and alleviate inflation concerns, further supporting stock market gains.
- Consumer Confidence Rises: The US March consumer confidence index unexpectedly increased by 0.8 to 91.8, surpassing expectations of a decline to 87.9, suggesting enhanced consumer confidence in economic prospects, which could drive spending and economic growth.
- Strong Chinese Economy: China's March manufacturing PMI rose to 50.4, exceeding expectations of 50.1, indicating signs of economic recovery that support global growth prospects and positively influence market performance.
See More








